| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $469,298,885 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08DK149188 | MMP7+ Hepatic Stellate Cells as Drivers of Fibrosis in Biliary Atresia | 000 | 1 | NIH | 8/27/2026 | $155,832 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH142589 | The role of the ventral CA1 in distinct social representations | 000 | 1 | NIH | 4/28/2026 | $701,763 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI199276 | Optimization of human cytomegalovirus neutralizing antibodies as effective viral therapeutics | 000 | 1 | NIH | 8/25/2026 | $838,493 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03AI196368 | Pilot project to elucidate the role of DDX60L in Ebola virus disease | 000 | 1 | NIH | 4/28/2026 | $183,875 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL183340 | Inflammatory Biosignatures for the Identification of Sickle Cell Associated Pain Phenotypes (IBIS-CAP) | 000 | 1 | NIH | 8/27/2026 | $834,899 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI194183 | Structural and proteomic studies of allergic immune responses | 000 | 1 | NIH | 8/27/2026 | $838,290 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3DA063211 | Cognitively-enhanced tDCS of the dorsolateral prefrontal cortex to reduce craving in opioid use disorder | 000 | 1 | NIH | 8/27/2026 | $749,153 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI195716 | The biology of type 2 memory B cells and their role in allergy persistence | 000 | 1 | NIH | 8/5/2026 | $816,016 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AG104751 | The Role of Alzheimer's Disease Risk Allele APOE4 in Oligodendrocyte Development and Function | 000 | 1 | NIH | 8/26/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31MH143291 | Neurocognitive Characterization of Interpersonal Dysfunction in Borderline Personality Disorder | 000 | 1 | NIH | 4/6/2026 | $49,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31DK148044 | PINK1 in the regulation of terminal erythroid maturation and enucleation | 001 | 1 | NIH | 8/13/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31DK148044 | PINK1 in the regulation of terminal erythroid maturation and enucleation | 000 | 1 | NIH | 8/13/2026 | $50,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA064588 | Single chromatin fiber multiomics in opioid use disorder brain | 000 | 1 | NIH | 8/25/2026 | $796,299 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK146271 | Understanding and exploiting muscle and liver contributions to RNA-Nanoparticle immunity | 001 | 1 | NIH | 7/17/2026 | -$4,419 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK146271 | Understanding and exploiting muscle and liver contributions to RNA-Nanoparticle immunity | 000 | 1 | NIH | 7/16/2026 | $746,897 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 001 | 1 | NIH | 4/24/2026 | $49,970 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG096298 | The risk of Alzheimer's disease and related dementias among individuals with Autism Spectrum Disorder (AsDRD) | 000 | 1 | NIH | 2/6/2026 | $575,377 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD122293 | Discovery of novel inhibitors of the AASS enzyme to treat glutaric aciduria type 1 through substrate reduction | 000 | 1 | NIH | 8/17/2026 | $726,448 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 001 | 1 | NIH | 3/26/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U19AI198423 | Immunologic Trajectories of Peanut Desensitization (INROADS) | 000 | 1 | NIH | 5/19/2026 | $1,444,950 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK145695 | Mechanisms of MASH-mediated CKD pathogenesis | 000 | 1 | NIH | 8/17/2026 | $889,856 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI203004 | Molecular Mechanisms of Pararubulavirus Entry and Fusion Activation | 001 | 1 | NIH | 8/10/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI203004 | Molecular Mechanisms of Pararubulavirus Entry and Fusion Activation | 000 | 1 | NIH | 8/10/2026 | $49,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 000 | 1 | NIH | 3/24/2026 | $400,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 000 | 1 | NIH | 3/24/2026 | $1,147,918 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA310749 | Improved Lung Cancer Screening Approaches for People Living with HIV | 000 | 1 | NIH | 6/23/2026 | $711,272 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL183586 | MAP SCD: Mechanisms for Actionable Place-Based Drivers of Health in Sickle Cell Disease | 000 | 1 | NIH | 8/5/2026 | $850,669 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK143587 | Mechanisms of Interoceptive Signaling in Mouse Colon | 000 | 1 | NIH | 8/18/2026 | $814,028 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R56AG093986 | A low-cost reusable EEG patch for detection and use of digital sleep biomarkers associated with AD/ADRD | 001 | 1 | NIH | 8/14/2026 | $124,103 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R56AG093986 | A low-cost reusable EEG patch for detection and use of digital sleep biomarkers associated with AD/ADRD | 000 | 1 | NIH | 8/12/2026 | $651,534 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21MH144609 | Mechanistic Dissection of SRRM2-Mediated RNA Splicing and Subnuclear RNA Organization in Human Neurons | 000 | 1 | NIH | 8/18/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA317126 | Elucidating novel functions of ATRX in-frame fusion proteins in neuroblastoma | 000 | 1 | NIH | 7/16/2026 | $431,970 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI202288 | Fate-Mapping and Genetic Dissection of B-to-T Feedback Circuits Shaping Germinal-Center Selection | 000 | 1 | NIH | 8/7/2026 | $210,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UG3AG105083 | Genomics-Empowered AI for Personalized Cancer Risk Assessment, Monitoring, and Prevention | 002 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK147153 | Podocyte-to-parietal epithelial cell signal by exosomes drives proliferative glomerulopathy | 000 | 1 | NIH | 4/17/2026 | $816,825 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NR020624 | TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer | 001 | 1 | NIH | 4/22/2026 | $83,948 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NR020624 | TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer | 000 | 1 | NIH | 2/27/2026 | $755,540 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32DK141191 | Immune-adipocyte Crosstalk in Adipose-selective Thermogenic Program | 000 | 2 | NIH | 7/28/2026 | $84,148 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AR085270 | Unraveling Epigenetic and Transcription Control in Understudied Skin Types | 000 | 2 | NIH | 8/7/2026 | $142,800 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R33DA056779 | Cue Reactivity Modulation in Methamphetamine Use Disorder | 000 | 3 | NIH | 3/19/2026 | $834,725 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31AI194793 | Evaluating Differences in Innate Immune Response to Highly Pathogenic H5N1 Viruses | 001 | 2 | NIH | 8/13/2026 | $52,714 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30AI194739 | Hepatocytes and skeletal myocytes shape immunity to mRNA-LNP encoded protein | 000 | 2 | NIH | 8/18/2026 | $55,114 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R24ES036007 | The Ghana Randomized Air Pollution and Health Study (GRAPHS) Cohort | 000 | 3 | NIH | 4/8/2026 | $327,404 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI198790 | Targeting A35 to Unlock Broad-Spectrum Human Immunity Against Orthopoxviruses | 000 | 1 | NIH | 9/1/2026 | $840,018 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI203173 | Complement-Bound Exosomes in Human Kidney Transplant Immunity | 000 | 1 | NIH | 9/1/2026 | $820,496 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K01MH139990 | Projection-specific mechanisms mediating postpartum stress effects on the maternal brain | 000 | 1 | NIH | 3/19/2026 | $717,688 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI200611 | High Avidity Multiepitope Targeting of RNA-induced cell surface HIV Env | 000 | 1 | NIH | 8/31/2026 | $832,773 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99ES037024 | Endocrine-Disrupting Chemical (EDC) Mixtures in Relation to Metabolic Syndrome (MetS) and Metabolomic Mechanisms in a Prospective Cohort of Hispanic Women | 000 | 2 | NIH | 8/10/2026 | $126,809 |
|
